Funding for Medical Research
and Clinical Trials
and Clinical Trials
Funding Details for Cancer
Use the contact information shown for the organization to apply for the funding.
Please notify CenTrial of any offer is incorrect or has expired.
Please notify CenTrial of any offer is incorrect or has expired.
Ovarian Cancer
Rivkin Center for Ovarian Cancer Research
Type of Organization: Foundation
Contact Name: Jackie Lang
Email Address: jackie.lang@rivkin.org
Funds Available for Clinical Trials: ✗ Research: ✔
Other info: Bridge Funding allows researchers to produce data needed to substantiate their proposal resubmission to federal funding agencies for a promising new research project. The Rivkin Center provides interim funding of up to $30,000 to researchers who have submitted an R01 or R21 proposal to the National Institutes of Health (NIH) or an original proposal to the Department of Defense (DoD) pertaining to ovarian cancer and who have not received, but were close to, a fundable score.
Rivkin Center for Ovarian Cancer Research
Type of Organization: Foundation
Contact Name: Jackie Lang
Email Address: jackie.lang@rivkin.org
Funds Available for Clinical Trials: ✗ Research: ✔
Funding Details
Requirements: Investigators at all levels are encouraged to apply. Unfunded first submission NIH R01, R21, K08, K23, and K99 proposals (no A1 or A2 proposals) as well as original DoD proposals are eligible for consideration. NIH proposals must have scored in the 20th percentile or lower, and DoD proposals must have scored 2.0 or less. Proposals must have received their agency score within the past 9 months. Proposals must require at least six months of additional research work prior to resubmission.Other info: Bridge Funding allows researchers to produce data needed to substantiate their proposal resubmission to federal funding agencies for a promising new research project. The Rivkin Center provides interim funding of up to $30,000 to researchers who have submitted an R01 or R21 proposal to the National Institutes of Health (NIH) or an original proposal to the Department of Defense (DoD) pertaining to ovarian cancer and who have not received, but were close to, a fundable score.